Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dempsey

Showing results (701-710 of 710) with videos related to

Pageof 71
Sort By:
You have reached the last page of results.This site can display upto 710 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34<sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 8, 2024
Association of amyloid and cardiovascular risk with cognition: Findings from KBASESoumilee Chaudhuri, Desarae A Dempsey, Yen-Ning Huang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 2, 2007
A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohortGirish V Putcha, Bassem A Bejjani, Stacey Bleoo, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 25, 2022
Prenatal phenotyping: A community effort to enhance the Human Phenotype OntologyFerdinand Dhombres, Patricia Morgan, Bimal P Chaudhari, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
The Metabolome as a Readout for Adverse Social Exposome Influences on Human Health - A Roadmap for Modifiable Factors and Proactive HealthNuanyi Liang, Siamak Mahmoudiandehkordi, Margo B Heston, et al.
Molecular Cancer Therapeutics|September 19, 2019
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor EfficacyJian Du, Lei Yan, Raquel Torres, et al.
Nature Communications|May 4, 2026
Characterization of KRAS<sup>G12C</sup> inhibitor olomorasib single-agent and combination with activity in KRAS<sup>G12C</sup>-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.
Human Mutation|March 8, 2012
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathyJohann Böhm, Valérie Biancalana, Elizabeth T Dechene, et al.
Pageof 71

Showing results (701-710 of 710) with videos related to

Sort By:
Pageof 71
You have reached the last page of results.This site can display upto 710 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34<sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 8, 2024
Association of amyloid and cardiovascular risk with cognition: Findings from KBASESoumilee Chaudhuri, Desarae A Dempsey, Yen-Ning Huang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 2, 2007
A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohortGirish V Putcha, Bassem A Bejjani, Stacey Bleoo, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 25, 2022
Prenatal phenotyping: A community effort to enhance the Human Phenotype OntologyFerdinand Dhombres, Patricia Morgan, Bimal P Chaudhari, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
The Metabolome as a Readout for Adverse Social Exposome Influences on Human Health - A Roadmap for Modifiable Factors and Proactive HealthNuanyi Liang, Siamak Mahmoudiandehkordi, Margo B Heston, et al.
Molecular Cancer Therapeutics|September 19, 2019
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor EfficacyJian Du, Lei Yan, Raquel Torres, et al.
Nature Communications|May 4, 2026
Characterization of KRAS<sup>G12C</sup> inhibitor olomorasib single-agent and combination with activity in KRAS<sup>G12C</sup>-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.
Human Mutation|March 8, 2012
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathyJohann Böhm, Valérie Biancalana, Elizabeth T Dechene, et al.
Pageof 71